Skip to main content

Peer Review reports

From: DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer

Original Submission
14 Oct 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
20 Nov 2014 Author responded Author comments - Javier Martinez-Useros
8 Nov 2014 Reviewed Reviewer Report - Zhenhua Lin
9 Nov 2014 Reviewed Reviewer Report - Lijuan Lin
10 Nov 2014 Reviewed Reviewer Report - Chunyu Li
Resubmission - Version 3
20 Nov 2014 Submitted Manuscript version 3
10 Dec 2014 Author responded Author comments - Javier Martinez-Useros
Resubmission - Version 4
10 Dec 2014 Submitted Manuscript version 4
Publishing
11 Dec 2014 Editorially accepted
16 Dec 2014 Article published 10.1186/1471-2407-14-965

You can find further information about peer review here.

Back to article page
\